Skip to main content

The ICRP System of Radiological Protection

By Troy Zhou, PhD, DABR, DABSNM
December 7, 2023 • 17 min read

Almost every radiation-safety rule a medical imaging or nuclear medicine facility follows — the occupational dose limits, the ALARA program, the requirement to justify each examination, the diagnostic reference levels — descends from a single conceptual framework: the system of radiological protection developed by the International Commission on Radiological Protection (ICRP). Its current form is set out in ICRP Publication 103, the 2007 recommendations, which rest on three principles — justification, optimization, and dose limitation — and on the protection quantity of effective dose.1

For a radiation safety officer or medical physicist, knowing the framework is more useful than memorizing individual limits. The framework explains why the limits are what they are, why they do not apply to patients, and how the many optimization tools — dose constraints, reference levels, diagnostic reference levels — fit together. This guide lays out the ICRP system, the quantities it uses, a worked effective-dose calculation, its clinical and programmatic impact, practical application, and the regulatory relationships that turn ICRP recommendations into enforceable rules.169

Introduction

The ICRP system is best understood as a coherent answer to one question: how do we conduct beneficial activities involving radiation while keeping the resulting harm acceptable and as small as reasonably achievable? Its answer is the three principles applied through a common, risk-related dose quantity, backed by a model of radiation detriment.1

The framework has evolved. ICRP Publication 26 (1977) introduced the effective dose equivalent and the dose-limitation system; ICRP Publication 60 (1991) refined the quantities and lowered the recommended occupational limit; and ICRP Publication 103 (2007) consolidated the three principles across all exposure situations, updated the tissue weighting factors, and re-based the detriment model.123 U.S. regulation in 10 CFR Part 20 was built largely on the Publication 26/60 generation, which is why some enforceable numbers in the United States differ from the latest ICRP values while sharing the same conceptual structure.9

Understanding that lineage matters in practice: it explains why an RSO applies a 50 mSv annual occupational limit under NRC rules while the current ICRP recommendation is 20 mSv per year averaged over five years, and why both are expressions of the same optimization-and-limitation philosophy rather than a contradiction.19

Topic Explanation

The three principles

The ICRP system is built on three principles that apply, with appropriate adaptation, across planned, emergency, and existing exposure situations.1

  • Justification. Any decision that alters the radiation exposure situation should do more good than harm. Introducing a new radiation source, or a new medical procedure, must produce a net benefit to the exposed individuals or to society.1
  • Optimization of protection. The likelihood of incurring exposures, the number of people exposed, and the magnitude of their individual doses should all be kept as low as reasonably achievable, economic and societal factors being taken into account. This is the ALARA principle, and it is applied prospectively with dose constraints (in planned situations) and reference levels (in emergency and existing situations).18
  • Limitation of doses. In planned exposure situations other than the medical exposure of patients, the total dose to any individual from regulated sources should not exceed the recommended dose limits.1

Justification and optimization apply to all three exposure situations; dose limitation applies only to planned situations and, critically, not to patients.1

The three exposure situations

Publication 103 organizes all exposures into three situations: planned (deliberate operation of sources, such as a nuclear medicine department), emergency (unexpected situations requiring urgent action), and existing (situations already present when a decision to control them is taken, such as radon in buildings).1 The three principles apply throughout, but the tools differ — dose limits and constraints in planned situations, reference levels in emergency and existing situations.1

The categories of exposure

The system also distinguishes three categories of exposure: occupational (incurred by workers as a result of their work), public (members of the public), and medical (patients, and separately, carers, comforters, and volunteers in research).1 Medical exposure of patients is deliberately excluded from dose limits because the exposure is intended to benefit that same individual; protection for patients is achieved through justification of the procedure and optimization of the dose, which is why imaging uses diagnostic reference levels rather than patient dose limits.16

Key Technical Principles

From absorbed dose to equivalent dose

The physical starting point is absorbed dose , the energy imparted per unit mass, in gray (Gy). Because different radiation types produce different biological damage per unit absorbed dose, the ICRP defines equivalent dose to a tissue by weighting the absorbed dose from each radiation type by a radiation weighting factor :

Equivalent dose is expressed in sieverts (Sv). In Publication 103 the radiation weighting factors are 1 for photons and electrons, 2 for protons, 20 for alpha particles, and an energy-dependent function for neutrons ranging from about 2.5 to 20.1 An internal alpha emitter that delivers 1 mGy of absorbed dose to a tissue therefore produces an equivalent dose of mSv — a twentyfold amplification that explains why internal contamination by alpha emitters is treated so seriously.1

From equivalent dose to effective dose

To capture whole-body stochastic risk from a non-uniform exposure, the ICRP defines effective dose as the sum of tissue equivalent doses weighted by tissue weighting factors :

The tissue weighting factors reflect each organ's relative contribution to total radiation detriment and sum to unity. In Publication 103 they are 0.12 for red bone marrow, colon, lung, stomach, breast, and the remainder tissues; 0.08 for the gonads; 0.04 for bladder, esophagus, liver, and thyroid; and 0.01 for bone surface, brain, salivary glands, and skin.1 Effective dose lets a partial-body exposure — a CT scan, an internal radiopharmaceutical — be reduced to a single number proportional to overall stochastic risk and added across sources and time.1

Radiation detriment and the nominal risk coefficient

The weighting factors are not arbitrary; they derive from radiation detriment, the ICRP's composite measure of harm that combines the probability of radiation-induced cancer and heritable effects with their lethality, the associated loss of quality of life, and the years of life lost.1 Publication 103 expresses the overall risk as a detriment-adjusted nominal risk coefficient of approximately 5.7% per Sv for the whole population and about 4.2% per Sv for an adult working population.1 These coefficients are appropriate for population protection at low doses, not for estimating the risk to a specific individual.1

Worked effective-dose example

Consider a radiopharmaceutical that delivers the following approximate organ equivalent doses to a patient (photon emitter, so and equivalent dose equals absorbed dose numerically):

Tissue Equivalent dose (mSv) (mSv)
Colon 10 0.12 1.20
Stomach 10 0.12 1.20
Lung 5 0.12 0.60
Gonads 4 0.08 0.32
Bladder 8 0.04 0.32
Liver 6 0.04 0.24
Effective dose ≈ 3.88

Summing the weighted contributions gives an effective dose of about 3.88 mSv:

A full calculation would include the remainder tissues and all exposed organs, but the example shows the mechanics: organs with the highest weighting factors dominate the effective dose, which is why protection and dose-reduction effort is directed at exposures to the most radiosensitive tissues.1

The linear no-threshold basis

For protection purposes the ICRP adopts the linear no-threshold (LNT) model for stochastic effects: risk is assumed proportional to dose with no threshold. LNT is a prudent operational assumption rather than a proven description of low-dose biology; it justifies the ALARA imperative and permits doses to be summed across sources and time, which the whole system depends on.1 Deterministic effects (tissue reactions) are treated separately, with thresholds; Publication 118 (2012) updated those thresholds, notably lowering the judged threshold for the lens of the eye and recommending a reduced occupational lens equivalent-dose limit.4

Clinical Impact

The ICRP framework shapes daily practice in every imaging and nuclear medicine department, usually invisibly. When a physician weighs whether a scan is warranted, that is justification. When a technologist uses the lowest dose that answers the clinical question, that is optimization. When an RSO tracks occupational badge readings against a limit, that is limitation. The framework is the reason these are treated as a connected system rather than unrelated rules.16

The exclusion of patients from dose limits is one of the most clinically consequential features. It means there is no regulatory ceiling on the dose a justified, optimized diagnostic or therapeutic procedure may deliver to a patient — the safeguard is instead the twin discipline of justification and optimization, supported by diagnostic reference levels that flag facilities whose typical doses are unusually high.16 Misunderstanding this point leads to two opposite errors: refusing a justified scan for fear of a nonexistent patient limit, or neglecting optimization on the assumption that "there is no limit anyway."6

Effective dose, too, is frequently misused clinically. It is a protection and comparison quantity based on population-averaged weighting factors and reference phantoms; it is not intended to estimate the risk to an individual patient of a specific age and sex. Communicating radiation risk to patients responsibly means using effective dose for comparison while acknowledging its limits as an individual risk predictor.16

Practical Optimization Tips

Apply the principles in order

Justify first, optimize always, and treat limits as a backstop, not a target. A dose below the limit is not automatically acceptable — optimization asks whether it could reasonably be lower.18

Use the right optimization tool for the situation

  • In planned situations, use dose constraints as prospective source-related upper values to guide optimization, and diagnostic reference levels for patient imaging.
  • In emergency and existing situations, use reference levels.
  • Never confuse any of these with a dose limit — constraints and reference levels are optimization aids, and exceeding a constraint triggers review, not a violation in the way exceeding a limit does.168

Keep occupational protection anchored to ALARA

Dose limits define the boundary of the tolerable; ALARA defines the goal. Investigation levels set below the regulatory limit — a common program design — operationalize optimization by prompting review well before a limit is approached.89

Separate stochastic from deterministic protection

Manage stochastic risk with effective dose and ALARA; manage deterministic risk (skin injury in interventional fluoroscopy, lens opacity) against thresholds and the specific equivalent-dose limits for the skin, extremities, and lens of the eye.14

Common misapplications

  1. Applying dose limits to patients — they do not apply; use justification, optimization, and reference levels.16
  2. Treating effective dose as an individual risk estimate — it is a population protection quantity.1
  3. Confusing a constraint or reference level with a limit — they are optimization tools.1
  4. Stopping optimization once a dose is under the limit — ALARA continues below the limit.8
  5. Ignoring deterministic thresholds in high-dose interventional work while focusing only on stochastic limits.4

Regulatory Considerations

The ICRP issues recommendations; regulators turn them into law. The chain runs from ICRP recommendations, through international standards such as the IAEA Basic Safety Standards (GSR Part 3) and U.S. guidance from the NCRP, to enforceable regulations such as the NRC's 10 CFR Part 20.1910 Understanding the chain explains why numerical limits differ across the world and across time while the framework is shared.

The table below compares current ICRP recommendations with U.S. NRC regulatory limits as they stood for planned occupational and public exposure. The differences reflect the regulatory generation each was drawn from, not a disagreement about the underlying system.

Quantity ICRP Publication 103 recommendation NRC 10 CFR Part 20 limit
Occupational effective dose 20 mSv/yr averaged over 5 yr (≤50 mSv in any year) 50 mSv/yr (5 rem)
Public effective dose 1 mSv/yr 1 mSv/yr (100 mrem)
Occupational lens of the eye 20 mSv/yr averaged over 5 yr (Publication 118) 150 mSv/yr (15 rem)
Occupational skin / extremities 500 mSv/yr 500 mSv/yr (50 rem)
Embryo/fetus (declared pregnancy) Constraint on the conceptus after declaration 5 mSv over the pregnancy (0.5 rem)

For a medical facility, the operative rules are the NRC or Agreement-State regulations for radioactive material and the state radiation-control program for radiation-producing machines. In Florida these are administered under Florida Administrative Code Chapter 64E-5, and DRPS also serves Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware, where the NRC or the Agreement-State authority imposes parallel requirements. Always confirm the applicable limits with the authority having jurisdiction, and recognize that they express the ICRP framework even where the numbers differ. For the component quantities and rules, see our guides to effective dose and tissue weighting factors and the NRC occupational dose limits in Part 20.

Frequently Asked Questions (FAQs)

What exactly are the three ICRP principles?

Justification (do more good than harm), optimization (keep doses as low as reasonably achievable using constraints and reference levels), and limitation (do not exceed individual dose limits in planned situations). They come from ICRP Publication 103.1

Why don't dose limits apply to patients?

Because the medical exposure is intended to benefit that individual. Patient protection is achieved through justification and optimization, supported by diagnostic reference levels rather than dose limits.16

What is the difference between equivalent dose and effective dose?

Equivalent dose weights absorbed dose by radiation type for a single tissue; effective dose sums the tissue equivalent doses weighted by tissue weighting factors into a whole-body-equivalent, risk-related quantity.1

Is effective dose a patient's risk?

No. It is a population-based protection quantity useful for comparison and summation, not an individual risk estimate for a specific patient.1

Why do NRC limits differ from current ICRP values?

U.S. limits derive largely from the ICRP Publication 26/60 generation, so some numbers differ from Publication 103 even though the framework is shared.19

Key Takeaways

  • The ICRP system rests on three principles: justification, optimization, and dose limitation.1
  • Justification and optimization apply to all exposure situations; dose limits apply only to planned situations and not to patients.1
  • Effective dose sums tissue equivalent doses weighted by tissue weighting factors into a single risk-related quantity.1
  • Tissue weighting factors derive from radiation detriment; the nominal risk coefficient is about 5.7% per Sv for the whole population.1
  • Dose constraints and reference levels are optimization tools, not limits.1
  • ICRP recommendations become enforceable through the NCRP, IAEA, and regulators such as the NRC, so numerical limits can differ while the framework is shared.1910

How DRPS Can Help

Diagnostic Radiation Physics Services (DRPS) supports imaging and nuclear medicine programs across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware with radiation safety officer support, ALARA program design, dose-limit and investigation-level structuring, and radiation safety training delivered by board-certified medical physicists.

A strong radiation protection program is not a list of numbers to stay under. It is the ICRP framework made operational — every procedure justified, every dose optimized, and every regulated exposure held within limits — so that the program is coherent, defensible, and genuinely protective.

Conclusion

The ICRP system of radiological protection is the intellectual backbone of radiation safety: three principles — justification, optimization, and dose limitation — expressed through the effective-dose quantity and grounded in a model of radiation detriment. Its power for a radiation safety program lies in coherence. The principles explain why patients are excluded from dose limits, why ALARA continues below any limit, why constraints and reference levels exist alongside limits, and why national regulations can differ in their numbers while sharing one philosophy. A medical physicist or RSO who works from the framework, not just the numbers, builds a program that holds together under scrutiny and actually protects people.169

Related Resources

References

  1. International Commission on Radiological Protection. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP. 2007;37(2-4):1-332. icrp.org
  2. International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann ICRP. 1991;21(1-3). icrp.org
  3. International Commission on Radiological Protection. Recommendations of the ICRP. ICRP Publication 26. Ann ICRP. 1977;1(3). icrp.org
  4. International Commission on Radiological Protection. ICRP Statement on Tissue Reactions / Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context. ICRP Publication 118. Ann ICRP. 2012;41(1-2). icrp.org
  5. International Commission on Radiological Protection. Radiological Protection in Medicine. ICRP Publication 105. Ann ICRP. 2007;37(6). icrp.org
  6. National Council on Radiation Protection and Measurements. Limitation of Exposure to Ionizing Radiation. NCRP Report No. 116. Bethesda, MD: NCRP; 1993. ncrponline.org
  7. National Council on Radiation Protection and Measurements. Ionizing Radiation Exposure of the Population of the United States. NCRP Report No. 160. Bethesda, MD: NCRP; 2009. ncrponline.org
  8. National Council on Radiation Protection and Measurements. Implementation of the Principle of As Low As Reasonably Achievable (ALARA) for Medical and Dental Personnel. NCRP Report No. 107 and related guidance. Bethesda, MD: NCRP. ncrponline.org
  9. U.S. Nuclear Regulatory Commission. 10 CFR Part 20, Standards for Protection Against Radiation. nrc.gov
  10. International Atomic Energy Agency. Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards. IAEA Safety Standards Series No. GSR Part 3. Vienna: IAEA; 2014. iaea.org